Brown & Brown Inc
NYSE:BRO
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Brown & Brown Inc
Cash Equivalents
Brown & Brown Inc
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Brown & Brown Inc
NYSE:BRO
|
Cash Equivalents
$581m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
13%
|
CAGR 10-Years
9%
|
|
Marsh & McLennan Companies Inc
NYSE:MMC
|
Cash Equivalents
$1.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
Arthur J Gallagher & Co
NYSE:AJG
|
Cash Equivalents
$1.8B
|
CAGR 3-Years
50%
|
CAGR 5-Years
15%
|
CAGR 10-Years
9%
|
|
Ryan Specialty Group Holdings Inc
NYSE:RYAN
|
Cash Equivalents
$838.8m
|
CAGR 3-Years
39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
BRP Group Inc
NASDAQ:BRP
|
Cash Equivalents
$116.2m
|
CAGR 3-Years
2%
|
CAGR 5-Years
71%
|
CAGR 10-Years
N/A
|
|
Hagerty Inc
NYSE:HGTY
|
Cash Equivalents
$108.3m
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Brown & Brown Inc's Cash Equivalents?
Cash Equivalents
581m
USD
Based on the financial report for Mar 31, 2024, Brown & Brown Inc's Cash Equivalents amounts to 581m USD.
What is Brown & Brown Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
9%
Over the last year, the Cash Equivalents growth was 3%. The average annual Cash Equivalents growth rates for Brown & Brown Inc have been -5% over the past three years , 13% over the past five years , and 9% over the past ten years .